Small Lymphocytic Lymphoma — Trials

Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

479 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 129
Recruiting: 67
Ph III recruiting: 9
Growth YoY: −23.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (108)

clinicaltrialsPublishedShowing 101–118 of 118 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00759603	Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia	completed	Phase 2	60	M.D. Anderson Cancer CenterOTHER	1	Aug 27, 2015	clinicaltrials
NCT01217749	Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL(PCYC-1109-CA)	completed	Phase 1 / Phase 2	71	Pharmacyclics LLC.INDUSTRY	1	Jun 25, 2015	clinicaltrials